Platform
Features
0 followers
Formed in late 2017, AMLo Biosciences is dedicated to providing a prognostic test for early AJCC Stage I and Stage II melanoma to better identify patients’ true risk of disease progression.
Industries
Headquarters
Employees
Links
Marie Labus
4 members
5 members
This company has no offices yet
Autolus
2 followers
Tessera Therapeutics
Vaxcyte
CN Bio Innovations
1 follower
University College London
18 followers
Sano Genetics
Incident.io
4 followers
CodeBase
3 followers
Arcellx
Vertice
Thermo Fisher Scientific
173 followers
Explore companies